ÂÜÀòÂÒÂ×

Caterina Brindicci is an accomplished professional in the field of respiratory and immunology, currently serving as SVP Global Head of Late Respiratory & Immunology at AstraZeneca, following a position as VP, Global Franchise Head of Respiratory & Immunology. Previous roles include VP of Clinical Development Head for Respiratory & Allergy at Novartis, where Caterina also acted as Global Program Clinical Head for multiple projects. Earlier experience includes significant positions at Chiesi Group as Project Coordinator of PROactive and Clinical Program Leader, as well as Clinical Research Physician at Royal Brompton Hospital. Caterina holds a PhD in Respiratory Medicine from Imperial College London and has a foundational degree from Università degli Studi di Bari.